Tango Therapeutics, Inc. (TNGX)
24.88
-0.63
(-2.47%)
USD |
NASDAQ |
May 14, 16:00
24.51
-0.37
(-1.49%)
After-Hours: 20:00
Tango Therapeutics EPS Diluted (Quarterly) : -0.2945 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Revolution Medicines, Inc. | -2.291 |
| Kodiak Sciences, Inc. | -0.9402 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Sarepta Therapeutics, Inc. | 2.878 |
| Hims & Hers Health, Inc. | -0.4034 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.75M |
| Total Expenses (Quarterly) | 38.75M |
| Enterprise Value | 3.330B |
| Earnings Yield | -3.47% |
| Normalized Earnings Yield | -3.474 |